A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients

Clinical Infectious Diseases

Volumn 45, Issue 12, 2007, Pages 1576-1582

  Kumar, Deepali ^a   Chen, Maggie Hong ^b   Welsh, Brenda ^a   Siegal, Deborah ^c   Cobos, Isabel ^a   Messner, Hans A ^b   Lipton, Jeff ^b   Humar, Atul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUSULFAN; CALCINEURIN INHIBITOR; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; PNEUMOCOCCUS VACCINE; PREDNISONE; UNCLASSIFIED DRUG; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; MENINGOCOCCUS VACCINE; VACCINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; DOUBLE BLIND PROCEDURE; DRUG FEVER; FEMALE; GEOMETRY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOGENICITY; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; STREPTOCOCCUS INFECTION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VACCINATION; ADULT; ALLOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LIVING DONOR; MIDDLE AGED; MULTIVARIATE ANALYSIS;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVING DONORS; MALE; MENINGOCOCCAL VACCINES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; TRANSPLANTATION, HOMOLOGOUS; VACCINES, CONJUGATE;

EID: 40449104823     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/523583     Document Type: Article

References (22)

1. Engelhard D, Cordonnier C, Shaw PJ, et al; Infectious Disease Working Party of the European Bone Marrow Transplantation. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 2002; 117:444-50.
2. Kulkarni S, Powles R, Treleaven J, et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 2000; 95:3683-6.
3. Youssef S, Rodriguez G, Rolston KV, Champlin RE, Raad II, Safdar A. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005. Medicine (Baltimore) 2007; 86:69-77.
4. Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Morb Mortal Wkly Rep 2000; 49(RR10):1-128.
5. Ljungman P, Engelhard D, de la Camara R, et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35:737-46.
6. Guinan EC, Molrine DC, Antin JH, et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994; 57:677-84.
7. Molrine DC, Guinan EC, Antin JH, et al. Donor immunization with hemophilus influenza type B (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87:3012-8.
8. Eskola J, Anttila M. Pneumococcal conjugate vaccines. Pediatr Infect Dis J 1999; 18:543-51.
9. Feikin DR, Elie CM, Goetz MB, et al. Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults. Vaccine 2001; 20:545-53.
10. Shelly MA, Jacoby H, Riley GJ, Graves BT, Pichichero M, Treanor JH. Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infect Immun 1997; 65:242-7.
11. Antin JH, Guinan EC, Avigan D, et al. Protective antibody responses to pneumocococcal conjugate vaccine after autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 213-22.
12. Kumar D, Rotstein C, Miyata G, Arlen D, Humar A. Randomized, double-blind controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis 2003; 187:1639-45.
13. Hausdorff W, Bryant J, Paradiso P, Siber G. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30:100-21.
14. Meisel R, Kuypers L, Dirksen U, et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation.Blood 2007; 109:2322-6.
15. Molrine DC, Antin JH, Guinan EC, et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101:831-6.
16. Wernette CM, Frasch CE, Madore D, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 2003; 10:514-9.
17. World Health Organization. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series No. 927, 2005. Available at: http://www.who.int/biologicals/publications/trs/ areas/vaccines/pneumo/en/index.html. Accessed 1 January 2007.
18. Henning KJ, White MH, Sepkowitz KA, Armstrong D. A national survey of immunization practices following allogeneic bone marrow transplantation. JAMA 1997; 277:1148-51.
19. Winston DJ, Ho WG, Schiffman G, Champlin RE, Feig SA, Gale RP. Pneumococcal vaccination of bone marrow transplants. Arch Intern Med 1983; 143:1735-7.
20. Giebink GS, Warkentin PI, Ramsay NK, Kersey JH. Titers of antibody to pneumococci in bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 1986; 154:590-6.
21. Parkkali T, Kayhty H, Anttila M, et al. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and haemophilus influenzae type b conjugate vaccines. Bone Marrow Transplant 1999; 24: 671-8.
22. Chan CY, Molrine DC, George S, et al. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease. J Infect Dis 1996; 173:256-8.